Abstract
(Abstracted from Int J Gynecol Cancer 2023;0:1–14) Low-grade serous carcinoma represents less than 10% of epithelial ovarian cancers, is often diagnosed in younger women, and is associated with prolonged survival relative to high-grade serous carcinoma. In 2019, a panel of experts gathered to address the unique needs of low-grade serous carcinoma management and published a consensus paper.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
